ArticleJournal of diabetes science and technology2023

Costs and Outcomes Comparison of Diabetes Technology Usage Among People With Type 1 or 2 Diabetes Using Rapid-Acting Insulin.

Carlos R Vallarino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.